Retrieve available abstracts of 11 articles: HTML format
Single Articles
October 2025
KO YS, Jin H, Lee SE, Won JY, et al A2AR-phospho-STAT1 (Y701)-HLA-E axis as a potential immune modulatory pathway in
radiotherapy-resistant triple negative breast cancer.
Carcinogenesis. 2025 Oct 22:bgaf069. doi: 10.1093. PubMedAbstract available
PARSYAN A, Athwal H, Bhat V, Allan AL, et al Polo-like Kinase 4 (PLK4) as a Therapeutic Target in Breast Cancer.
Carcinogenesis. 2025 Oct 14:bgaf067. doi: 10.1093. PubMedAbstract available
September 2025
Correction to: p62/SQSTM1 interacts with vimentin to enhance breast cancer
metastasis.
Carcinogenesis. 2025;46:bgaf042. PubMed
YADAV R, Goel S, Kumari L, Dahiya D, et al Expression profile of Claudins 3, 4, and 7 in breast tumors and its correlation
with clinicopathological features.
Carcinogenesis. 2025;46:bgaf049. PubMedAbstract available
JEYAKUMAR E, Sundararaju S, Annett S, Elrayess MA, et al Mammary Adipose Dysfunction in the Dual Epidemic of Obesity and Breast Cancer.
Carcinogenesis. 2025 Sep 3:bgaf053. doi: 10.1093. PubMedAbstract available
August 2025
WANG J, Wang D, Zhang X, Xu X, et al HECTD3 E3 ligase mediates ubiquitination of AKT-phosphorylated CMTM3 in
HER2-overexpressed breast cancer cells.
Carcinogenesis. 2025 Aug 21:bgaf048. doi: 10.1093. PubMedAbstract available
April 2025
GODINA C, Rosendahl AH, Goncalves de Oliveira K, Khazaei S, et al Genetic determinants and clinical significance of circulating and tumor-specific
levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish
breast cancer cohort.
Carcinogenesis. 2025 Apr 15:bgaf020. doi: 10.1093. PubMedAbstract available
ZHANG Y, Li Q, Lan J, Xie G, et al Triple-negative breast cancer molecular subtypes and potential detection targets
for biological therapy indications.
Carcinogenesis. 2025;46:bgaf006. PubMedAbstract available
PENG C, Liu Y, Heng YJ, Bodelon C, et al The impact of reproductive factors on breast tumor and normal-adjacent tissue
immune profile from menarche to menopause.
Carcinogenesis. 2025;46:bgaf028. PubMedAbstract available
January 2025
ZHU Y, Song Y, Zhou X, Zhang W, et al Antibody-Drug Conjugates in breast cancer.
Carcinogenesis. 2025 Jan 1:bgae082. doi: 10.1093. PubMedAbstract available
March 2024
KIM H, Son S, Ko Y, Lim H, et al CYR61 confers chemoresistance by upregulating survivin expression in
triple-negative breast cancer.
Carcinogenesis. 2024 Mar 6:bgae013. doi: 10.1093. PubMedAbstract available